Literature DB >> 8580119

Apparent absence of famotidine-antipsychotic drug interactions in patients with chronic schizophrenia.

G D Prell, R B Rosse, S I Deutsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8580119      PMCID： PMC1188739     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  9 in total

1.  Effect of famotidine on deficit symptoms of schizophrenia.

Authors:  R Kaminsky; T M Moriarty; J Bodine; D E Wolf; M Davidson
Journal:  Lancet       Date:  1990-06-02       Impact factor: 79.321

Review 2.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.

Authors:  S I Deutsch; R B Rosse; K A Kendrick; M Fay-McCarthy; J P Collins; R J Wyatt
Journal:  Clin Neuropharmacol       Date:  1993-12       Impact factor: 1.592

4.  An open-label study of famotidine as a treatment for schizophrenia.

Authors:  H A Whiteford; T J Stedman; J J McGrath; J Welham; S Pond
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

5.  Famotidine adjunctive pharmacotherapy of schizophrenia: a case report.

Authors:  R B Rosse; K Kendrick; L C Tsui; M Fay-McCarthy; J P Collins; P Rosenberg; R J Wyatt; S I Deutsch
Journal:  Clin Neuropharmacol       Date:  1995-08       Impact factor: 1.592

6.  Famotidine as an adjunct treatment of resistant schizophrenia.

Authors:  L K Oyewumi; D Vollick; H Merskey; C Plumb
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

7.  Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.

Authors:  G D Prell; J P Green; C A Kaufmann; J K Khandelwal; A M Morrishow; D G Kirch; M Linnoila; R J Wyatt
Journal:  Schizophr Res       Date:  1995-01       Impact factor: 4.939

8.  Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia.

Authors:  T Nakai; N Kitamura; T Hashimoto; Y Kajimoto; N Nishino; T Mita; C Tanaka
Journal:  Biol Psychiatry       Date:  1991-08-15       Impact factor: 13.382

9.  Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.

Authors:  M I Martínez-Mir; H Pollard; J Moreau; E Traiffort; M Ruat; J C Schwartz; J M Palacios
Journal:  Synapse       Date:  1993-11       Impact factor: 2.562
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.